基因稳定的多基因编辑的iPSC衍生NK细胞用于增强癌症免疫治疗
Daekee Kwon1, Bo Kyung Moon1, Mijung Han1
1Research Institute, Maru Therapeutics Co., Ltd., B-1209, Mstate, 114, Beobwon-ro, Songpa-gu, Seoul 05854, South Korea.
Molecular therapy. Oncology
|March 17, 2025
概括
研究人员从诱导的多能干细胞中开发出通用和强大的CAR-NK细胞. 这种现成的细胞疗法为B细胞血液癌症的CAR-T细胞治疗提供了更安全,更实惠的替代方案.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞工程 细胞工程
- 血液瘤学 血液瘤学
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法对B细胞血液癌症具有前景,但具有显著的副作用和高成本.
- 现成的CAR自然杀手 (NK) 细胞是对自身的CAR-T细胞的潜在替代品.
- 开发一种易于获得,有效和安全的CAR-NK细胞疗法对于更广泛的临床应用至关重要.
研究的目的:
- 通过细胞重编程,基因编辑和分化开发一种"完全现成"的CAR-NK细胞产品.
- 为了验证开发的CAR-NK细胞治疗B细胞血液癌症的疗效和安全性.
主要方法:
- 通过精确的基因编辑,生成基因稳定的通用和强大的CAR (upCAR) 诱导的多能干细胞 (iPSC).
- 将upCAR-iPSCs分化为具有高产量和增殖能力的upCAR-NK细胞.
- 评估upCAR-NK细胞功能,包括干扰素-γ分泌,细胞毒性和体内/体外安全性.
主要成果:
- 基因稳定的upCAR-iPSCs被产生,没有异于目标效应.
- upCAR-NK细胞表现出高分化的产量,体外增殖和成功的冷保存.
- upCAR-NK细胞在体外和体内对癌细胞表现出强烈的细胞毒性作用,没有观察到毒性.
结论:
- 这项研究建立了一个基因稳定的upCAR-iPSC和upCAR-NK细胞平台技术.
- 开发的平台为B细胞血液癌症的CAR-T细胞提供了一个潜在的更安全,更经济,更有效的替代方案.
- 这项技术为开发低成本,高效,现成的CAR-NK细胞疗法,并减少副作用铺平了道路.
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823


